文献速递淋巴瘤

原发性支气管相关淋巴组织边缘区淋巴瘤的主动监测策略

Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
PubMed 文献 · Blood Adv · 2021-01-01

该回顾性研究比较了原发性BALT淋巴瘤的三种初始管理策略:主动监测、手术切除和全身治疗。中位随访超过60个月,手术切除的EFS优于主动监测和全身治疗,但所有组6年OS均极好。BALT淋巴瘤呈惰性病程,常可多年无需治疗。

要点

  • BALT淋巴瘤呈惰性,主动监测是合理选择,常可多年无需治疗。
  • 手术切除的EFS优于主动监测和全身治疗(6年EFS:74% vs 65% vs 62%,P=.013)。
  • 所有组6年OS均达93%,手术组100%略优(P=.024)。

核心结论

  • BALT淋巴瘤呈惰性病程,常可采取期待观察策略而多年无需治疗。
  • 手术切除在EFS上优于主动监测和全身治疗,但各组OS均极好。

研究设计与样本

  • 回顾性研究,纳入1995-2017年Memorial Sloan Kettering Cancer Center连续200例肺MZL患者,其中123例符合原发性BALT淋巴瘤标准。
  • 原发性BALT淋巴瘤定义为病变局限于肺和邻近淋巴结。
  • 主动监测定义为有记录的观察计划且治疗前随访≥3个月。

主要发现

  • 123例患者中,主动监测47%,完整手术切除41%,全身化疗或免疫治疗11%。
  • 中位随访>60个月,手术切除相比主动监测和全身治疗的6年EFS分别为74% vs 65% vs 62%(P=.013)。
  • 较大的病灶和血小板减少与更短的EFS相关。
  • 所有组6年OS为93%,手术切除100%略优于主动监测91%和全身治疗76%(P=.024)。

关键数值与推荐

  • 6年EFS:手术切除74%,主动监测65%,全身治疗62%(P=.013)。
  • 6年OS:手术切除100%,主动监测91%,全身治疗76%(P=.024)。

临床怎么用

  • BALT淋巴瘤诊断后可优先考虑主动监测,避免过早干预。
  • 对于适合手术的患者,手术切除可能改善EFS,但需权衡手术风险。
  • 较大病灶和血小板减少提示EFS较短,需密切随访。

局限性

  • 回顾性研究设计。
  • 单中心研究。
  • 样本量有限(123例)。
  • 治疗分组非随机,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although patients with bronchus-associated lymphoid tissue (BALT) lymphoma show an indolent clinical course, appropriate disease management at diagnosis is not well defined. This study aimed to compare 3 treatment strategies for patients with BALT lymphoma: active surveillance, systemic chemotherapy or immunotherapy at diagnosis, or complete surgical resection at diagnosis. We conducted a retrospective study of all patients with new diagnoses of marginal zone lymphoma (MZL) involving the lung who were treated at the Memorial Sloan Kettering Cancer Center between 1995 and 2017. Primary BALT lymphoma was defined as disease confined to the lungs and adjacent lymph nodes. Active surveillance was defined as a documented observation plan and ≥3 months of follow-up before initiating treatment. Overall survival (OS) and event-free survival (EFS) were compared between treatment groups. We reviewed 200 consecutive patients with MZL involving the lung; 123 met the inclusion criteria and were managed by active surveillance (47%), complete surgical resection (41%), or systemic chemotherapy or immunotherapy (11%). With a median follow-up of >60 months, surgical resection was associated with a superior EFS compared with active surveillance and systemic treatment (6-year EFS: 74% vs 65% vs 62%, respectively; P = .013). Larger lesions and thrombocytopenia were associated with shorter EFS. All groups had excellent OS at 6 years (93%), albeit with a slight superiority for surgical resection (100%) over active surveillance (91%) and systemic treatment (76%) (P = .024). BALT lymphoma is an indolent disease that can often be managed expectantly and not require therapy for many years.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Joffe E, Leyfman Y, Drill E, et al. Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue. Blood Adv. 2021. PMID: 33496731. doi:10.1182/bloodadvances.2020003213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。